The cancer research campaign, an initiative courtesy of Saks Fifth Avenue, has always featured A-list pairings: who can forget Karl Lagerfeld and Gwyneth Paltrow or Julianne Moore and Jason Wu?
2016 is the first time that Saks has partnered with an accessories brand, clearly impressed by both Louboutin’s signature red souls and his philanthropic soul.
In the campaign, the stunning, Oscar-winning Berry sports ripped jeans and pumps along with the designer’s signature white tee, which features a trompe l’oeil necklace and an illustration of a pink stiletto emblazoned on the front.
The campaign will launch on Oct. 1, when the shirt will be available for $35 at all Saks Fifth Avenue locations in U.S. including its Beverly Hills store at 9600 Wilshire Boulevard, and Canada as well as on saks.com and saksoff5th.com. For the second year in a row, 100 percent of the T-shirts’ sales will benefit Stand Up to Cancer, an offshoot of the Entertainment Industry Foundation (EIF) that was created primarily to further cancer research.
Since the campaign’s inception nearly 18 years ago, Saks Fifth Avenue has donated nearly $40 million to cancer research and treatment organizations throughout the United States. Organizations which benefitted from Saks Fifth Avenue’s charitable support included: The Breast Cancer Research Foundation, EIF’s Women’s Cancer Research Fund, Cleveland Clinic, Boston’s Dana-Farber Cancer Institute, Nevada Cancer Institute and many more.
“Key To The Cure is one of the most important and valuable fund-raising and charitable initiatives that Saks undertakes,” says Marc Metrick, President, Saks Fifth Avenue. “We are committed to supporting the causes we believe in, and at almost two decades old, this annual campaign has raised close to $40 million for cancer research and treatment organizations throughout the United States. This year, we are thrilled to collaborate with SU2C for the second year in a row, as well as have the support of Halle Berry and Christian Louboutin on our extraordinary campaign to fund cancer research and treatment.”